Fetal monitoring analysis Market By Product (Instruments & Consumables, and Software), Application (Antepartum Fetal Monitoring, and Intrapartum Fetal Monitoring,), By Method (Non-invasive Method, and Invasive Method), By End-User (Hospitals Clinic, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Description

Market Overview      

The global Fetal monitoring analysis market accounted for USD 2.2 Billion in 2020 and is expected to reach USD 3.8 Billion by 2028, growing at a CAGR of 7.0% from 2021 to 2028.   

Fetal monitoring are the instruments used to record the heartbeat of the fetus. The method depends on the ob-gyn and hospital policies, also depend on the risk of problems. The instruments are used to analyze and monitor the chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, and jaundice.

COVID-19 Impact Analysis:

The global Fetal monitoring analysis market has witnessed a slight decrease due to the lockdown enforcement placed by various governments in order to contain COVID spreading. People had no option but to remain indoor, so the sales of instrument had decrease drastically. The restrictions imposed by various nations to contain COVID had stopped the production resulting in a disruption across the whole supply chain. However, the world markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.  

Growth Factors

Major boosting factors for fetal monitoring analysis market are increasing non-government and government initiatives for fetal & maternal health all over the world, as per the analysts at Zion Market Research. In addition to this, rising awareness of manufacturers and willingness of players to spend in the development of fetal monitoring is also powering the development of fetal monitoring analysis market. Moreover, enhanced models that assist to calculate the maternal parameters such as maternal heart rate, and blood pressure are also likely to fuel the development of fetal monitoring analysis market in coming years. On the other hand, lack of intervening guidelines and technological challenges might hamper the development of the global fetal monitoring analysis market in the years to come.

Report Scope:

Segment Analysis Preview  

On the basis of products, the fetal monitoring analysis market is likely to be ruled by consumable & instruments in years to come due to rising premature delivery rate, maternal mortality rate, and technological enhancements. Application sector of fetal monitoring analysis market is likely to be dominated by the antepartum section. Technological inventions an R&D of new products are likely to power the development of fetal monitoring analysis market in the years to come.

Depending on application, antepartum segment is likely to hold the major share in the market and is anticipated to remain dominant throughout the forecast period. This is attributed to the increase in number of chronic illness such as, autoimmune disorders, high blood pressure, and diabetes, in mother.

On the basis of end user, hospital segment hold the majority of fetal monitoring market share 2019, owing to strong presence of hospitals across the globe, and owing to enhanced fetal monitoring devices provided by hospitals and availability of skilled physicians and infrastructure.

Key Market Players & Competitive Landscape

Some of key players in Fetal monitoring analysis Market are Ge Healthcare, Siemens Healthcare, Philips Healthcare, Analogic Corporation, Neoventa Medical AB, Covidien PLC, Spacelabs Healthcare, Arjohuntleigh, Inc., Fujifilm Sonosite, Inc., and Natus Medical Incorporated among others.

The global Fetal monitoring analysis Market is segmented as follows:   

By Product

• Instruments & Consumables
  • Ultrasound & ultrasonography
  • Electronic fetal monitoring
  • Fetal electrodes
  • Fetal doppler
  • Uterine contraction monitor
  • Telemetry solutions
  • Accessories & consumables
• Software

By Application

• Antepartum Fetal Monitoring
• Intrapartum Fetal Monitoring

By Method

• Non-invasive Method
• Invasive Method

By End-User

• Hospitals
• Clinic
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter No. 1 Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2 Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Product
      • 2.1.1.2. Market Attractiveness Analysis, By Application
      • 2.1.1.3. Market Attractiveness Analysis, By Method
      • 2.1.1.4. Market Attractiveness Analysis, By End-User
      • 2.1.1.5. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Fetal monitoring analysis Market, 2016 – 2028 (USD Billion)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3 COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4 Fetal monitoring analysis Market – Product Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
  • 4.2. Instruments & Consumables
    • 4.2.1. Market Size and Forecast, By Region (USD Billion)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.2.4. Ultrasound & ultrasonography
    • 4.2.4.1 Market Size and Forecast, By Region (USD Billion)
    • 4.2.5. Ultrasound & ultrasonography
    • 4.2.5.1 Market Size and Forecast, By Region (USD Billion)
    • 4.2.6. Electronic fetal monitoring
    • 4.2.6.1 Market Size and Forecast, By Region (USD Billion)
    • 4.2.7. Fetal electrodes
    • 4.2.7.1 Market Size and Forecast, By Region (USD Billion)
    • 4.2.8. Uterine contraction monitor
    • 4.2.8.1 Market Size and Forecast, By Region (USD Billion)
    • 4.2.9. Telemetry sulutions
    • 4.2.9.1 Market Size and Forecast, By Region (USD Billion)
    • 4.2.10. Accessories & consumables
    • 4.2.10.1 Market Size and Forecast, By Region (USD Billion)
  • 4.3. Software
    • 4.3.1. Market Size and Forecast, By Region (USD Billion)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 5 Fetal monitoring analysis Market – Application Segment Analysis
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
  • 5.2. Antepartum Fetal Monitoring
    • 5.2.1. Market Size and Forecast, By Region (USD Billion)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Intrapartum Fetal Monitoring
    • 5.3.1. Market Size and Forecast, By Region (USD Billion)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 6 Fetal monitoring analysis Market – Method Segment Analysis
  • 6.1. Overview
    • 6.1.1. Market Revenue Share, By Method, 2020 & 2028
  • 6.2. Non-invasive Method
    • 6.2.1. Market Size and Forecast, By Region (USD Billion)
    • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 6.3. Invasive Method
    • 6.3.1. Market Size and Forecast, By Region (USD Billion)
    • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 7 Fetal monitoring analysis Market – End-User Segment Analysis
  • 7.1. Overview
    • 7.1.1. Market Revenue Share, By Method, 2020 & 2028
  • 7.2. Hospitals
    • 7.2.1. Market Size and Forecast, By Region (USD Billion)
    • 7.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 7.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 7.3. Clinic
    • 7.3.1. Market Size and Forecast, By Region (USD Billion)
    • 7.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 7.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 7.4. Others
    • 7.4.1. Market Size and Forecast, By Region (USD Billion)
    • 7.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 7.4.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 8 Fetal monitoring analysis Market – Regional Analysis
  • 8.1. Overview
    • 8.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 8.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
  • 8.2. North America
    • 8.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 8.2.2. North America Market Revenue, By Product, 2016 – 2028
    • 8.2.3. North America Market Revenue, By Application, 2016 – 2028
    • 8.2.4. North America Market Revenue, By Method, 2016 – 2028
    • 8.2.5. North America Market Revenue, By End-User, 2016 – 2028
    • 8.2.6. U.S.
      • 8.2.6.1. U.S. Market Revenue, By Product, 2016 – 2028
      • 8.2.6.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 8.2.6.3. U.S. Market Revenue, By Method, 2016 – 2028
      • 8.2.6.4. U.S. Market Revenue, By End-User, 2016 – 2028
    • 8.2.7. Canada
      • 8.2.7.1. Canada Market Revenue, By Product, 2016 – 2028
      • 8.2.7.2. Canada Market Revenue, By Application, 2016 – 2028
      • 8.2.7.3. Canada Market Revenue, By Method, 2016 – 2028
      • 8.2.7.4. Canada Market Revenue, By End-User, 2016 – 2028
    • 8.2.8. Mexico
      • 8.2.8.1. Mexico Market Revenue, By Product, 2016 – 2028
      • 8.2.8.2. Mexico Market Revenue, By Application, 2016 – 2028
      • 8.2.8.3. Mexico Market Revenue, By Method, 2016 – 2028
      • 8.2.8.4. Mexico Market Revenue, By End-User, 2016 – 2028
  • 8.3. Europe
    • 8.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 8.3.2. Europe Market Revenue, By Product, 2016 – 2028
    • 8.3.3. Europe Market Revenue, By Application, 2016 – 2028
    • 8.3.4. Europe Market Revenue, By Method, 2016 – 2028
    • 8.3.5. Europe Market Revenue, By End-User, 2016 – 2028
    • 8.3.6. Germany
      • 8.3.6.1. Germany Market Revenue, By Product, 2016 – 2028
      • 8.3.6.2. Germany Market Revenue, By Application, 2016 – 2028
      • 8.3.6.3. Germany Market Revenue, By Method, 2016 – 2028
      • 8.3.6.4. Germany Market Revenue, By End-User, 2016 – 2028
    • 8.3.7. France
      • 8.3.7.1. France Market Revenue, By Product, 2016 – 2028
      • 8.3.7.2. France Market Revenue, By Application, 2016 – 2028
      • 8.3.7.3. France Market Revenue, By Method, 2016 – 2028
      • 8.3.7.4. France Market Revenue, By End-User, 2016 – 2028
    • 8.3.8. U.K.
      • 8.3.8.1. U.K. Market Revenue, By Product, 2016 – 2028
      • 8.3.8.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 8.3.8.3. U.K. Market Revenue, By Method, 2016 – 2028
      • 8.3.8.4. U.K. Market Revenue, By End-User, 2016 – 2028
    • 8.3.9. Italy
      • 8.3.9.1. Italy Market Revenue, By Product, 2016 – 2028
      • 8.3.9.2. Italy Market Revenue, By Application, 2016 – 2028
      • 8.3.9.3. Italy Market Revenue, By Method, 2016 – 2028
      • 8.3.9.4. Italy Market Revenue, By End-User, 2016 – 2028
    • 8.3.10. Spain
      • 8.3.10.1. Spain Market Revenue, By Product, 2016 – 2028
      • 8.3.10.2. Spain Market Revenue, By Application, 2016 – 2028
      • 8.3.10.3. Spain Market Revenue, By Method, 2016 – 2028
      • 8.3.10.4. Spain Market Revenue, By End-User, 2016 – 2028
    • 8.3.11. Rest of Europe
      • 8.3.11.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
      • 8.3.11.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
      • 8.3.11.3. Rest of Europe Market Revenue, By Method, 2016 – 2028
      • 8.3.11.4. Rest of Europe Market Revenue, By End-User, 2016 – 2028
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 8.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
    • 8.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 8.4.4. Asia Pacific Market Revenue, By Method, 2016 – 2028
    • 8.4.5. Asia Pacific Market Revenue, By End-User, 2016 – 2028
    • 8.4.5. China
      • 8.4.5.1. China Market Revenue, By Product, 2016 – 2028
      • 8.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 8.4.5.3. China Market Revenue, By Method, 2016 – 2028
      • 8.4.5.4. China Market Revenue, By End-User, 2016 – 2028
    • 8.4.6. Japan
      • 8.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
      • 8.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 8.4.6.3. Japan Market Revenue, By Method, 2016 – 2028
      • 8.4.6.4. Japan Market Revenue, By End-User, 2016 – 2028
    • 8.4.7. India
      • 8.4.7.1. India Market Revenue, By Product, 2016 – 2028
      • 8.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 8.4.7.3. India Market Revenue, By Method, 2016 – 2028
      • 8.4.7.4. India Market Revenue, By End-User, 2016 – 2028
    • 8.4.8. South Korea
      • 8.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
      • 8.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 8.4.8.3. South Korea Market Revenue, By Method, 2016 – 2028
      • 8.4.8.4. South Korea Market Revenue, By End-User, 2016 – 2028
    • 8.4.9. South-East Asia
      • 8.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
      • 8.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 8.4.9.3. South-East Asia Market Revenue, By Method, 2016 – 2028
      • 8.4.9.4. South-East Asia Market Revenue, By End-User, 2016 – 2028
    • 8.4.10. Rest of Asia Pacific
      • 8.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 8.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 8.4.10.3. Rest of Asia Pacific Market Revenue, By Method, 2016 – 2028
      • 8.4.10.4. Rest of Asia Pacific Market Revenue, By End-User, 2016 – 2028
  • 8.5. Latin America
    • 8.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 8.5.2. Latin America Market Revenue, By Product, 2016 – 2028
    • 8.5.3. Latin America Market Revenue, By Application, 2016 – 2028
    • 8.5.4. Latin America Market Revenue, By Method, 2016 – 2028
    • 8.5.5. Latin America Market Revenue, By End-User, 2016 – 2028
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
      • 8.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 8.5.5.3. Brazil Market Revenue, By Method, 2016 – 2028
      • 8.5.5.4. Brazil Market Revenue, By End-User, 2016 – 2028
    • 8.5.6. Argentina
      • 8.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
      • 8.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 8.5.6.3. Argentina Market Revenue, By Method, 2016 – 2028
      • 8.5.6.4. Argentina Market Revenue, By End-User, 2016 – 2028
    • 8.5.7. Rest of Latin America
      • 8.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
      • 8.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
      • 8.5.7.3. Rest of Latin America Market Revenue, By Method, 2016 – 2028
      • 8.5.7.4. Rest of Latin America Market Revenue, By End-User, 2016 – 2028
  • 8.6. The Middle-East and Africa
    • 8.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 8.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
    • 8.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
    • 8.6.4. The Middle-East and Africa Market Revenue, By Method, 2016 – 2028
    • 8.6.5. The Middle-East and Africa Market Revenue, By End-User, 2016 – 2028
    • 8.6.5. GCC Countries
      • 8.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
      • 8.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 8.6.5.3. GCC Countries Market Revenue, By Method, 2016 – 2028
      • 8.6.5.4. GCC Countries Market Revenue, By End-User, 2016 – 2028
    • 8.6.6. South Africa
      • 8.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
      • 8.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 8.6.6.3. South Africa Market Revenue, By Method, 2016 – 2028
      • 8.6.6.4. South Africa Market Revenue, By End-User, 2016 – 2028
    • 8.6.7. Rest of Middle-East Africa
      • 8.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
      • 8.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
      • 8.6.7.3. Rest of Middle-East Africa Market Revenue, By Method, 2016 – 2028
      • 8.6.7.4. Rest of Middle-East Africa Market Revenue, By End-User, 2016 – 2028
• Chapter No. 8 Fetal monitoring analysis Market – Industry Analysis
  • 8.1. Introduction
  • 8.2. Market Drivers
    • 8.2.1. Driving Factor 1 Analysis
    • 8.2.2. Driving Factor 2 Analysis
  • 8.3. Market Restraints
    • 8.3.1. Restraining Factor Analysis
  • 8.4. Market Opportunities
    • 8.4.1. Market Opportunity Analysis
  • 8.5. Porter’s Five Forces Analysis
  • 8.6. PEST Analysis
  • 8.7. Regulatory Landscape
  • 8.8. Method Landscape
  • 8.9. Regional Market Trends
    • 8.9.1. North America
    • 8.9.2. Europe
    • 8.9.3. Asia Pacific
    • 8.9.4. Latin America
    • 8.9.5. The Middle-East and Africa
  • 8.10. Pricing Analysis
  • 8.11. Value Chain Analysis
  • 8.12. Downstream Buyers
  • 8.13. Distributors/Traders List
• Chapter No. 9 Competitive Landscape
  • 9.1. Company Market Share Analysis – 2019
    • 9.1.1. Global Fetal monitoring analysis Market: Company Market Share, 2019
    • 9.1.2. Global Fetal monitoring analysis Market, Company Market Revenue, 2016 – 2019 (USD Billion)
    • 9.1.3. Global Fetal monitoring analysis Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 9.1.4. Global Fetal monitoring analysis Market: Radar Determinant Chart, 2019
  • 9.2. Strategic Developments
    • 9.2.1. Acquisitions & Mergers
    • 9.2.2. New Product Launch
    • 9.2.3. Regional Expansion
  • 9.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 10 Company Profiles
  • 10.1. GE HEALTHCARE
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Product Portfulio
    • 10.1.4. Financial Overview
    • 10.1.5. Operating Business Segments
    • 10.1.6. Business Performance
    • 10.1.7. Recent Developments
  • 10.2. Siemens
  • 10.3. Philips Healthcare
  • 10.4. Analogic Corporation
  • 10.5. Neoventa Medical AB
  • 10.6. Covidien PLC
  • 10.7. Spacelabs Healthcare
  • 10.8. Arjohuntleigh, Inc
  • 10.9. Fujifilm Sonosite, Inc
• Chapter No. 11 Marketing Strategy Analysis
  • 11.1. Marketing Channel
  • 11.2. Direct Marketing
  • 11.3. Indirect Marketing
  • 11.4. Marketing Channel Development Trends
  • 11.5. Economic/Pulitical Environmental Change
• Chapter No. 12 Research Methodulogy
  • 12.1. Research Methodulogy
  • 12.2. Phase I - Secondary Research
  • 12.3. Phase II - Data Modeling
    • 12.3.1. Company Share Analysis Model
    • 12.3.2. Revenue Based Modeling
  • 12.4. Phase III - Primary Research
  • 12.5. Research Limitations
    • 12.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Fetal Monitoring Analysis market. Zion Research has collected and analyzed key data belong to the global Fetal Monitoring Analysis market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Fetal Monitoring Analysis across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Fetal Monitoring Analysis industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

• Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
• Helps in validating and strengthening the secondary research findings
• Further, develops the analysis team’s expertise and market understanding
• Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

• Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
• Purchasing managers, technical personnel, distributors and resellers
• Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

• Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
• IDC and other relevant magazines
• Internal and external proprietary databases, and relevant patent and regulatory databases
• National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Fetal Monitoring Analysis market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

• Demographic data: Population split by segments
• Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
• Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
• Data is then cross-checked by an expert panel.

Free Analysis

Fetal monitors play an important role in prenatal and maternal care by reducing mortality rate during childbirth. Fetal monitoring is used to record the fetal vital physiological functions by using an instrument. Pre-term and premature births are necessitating the need for continuous fetal monitoring. In last few years, the rate of preterm births increased rapidly. In addition, increasing prevalence of cardiopulmonary diseases, technological advancement such as noninvasive surgeries, increasing multiple births due to rising success rate of in vitro fertilization (IVF) procedures are expected to increase the demand for fetal monitoring analysis in coming five years.

Fetal monitoring analysis market is expected to witness a significant growth in coming five years owing to rapid technological advancement in the healthcare industry, increasing incidences of cardiopulmonary diseases, increase in a number of post-term pregnancy, government and non-government initiatives for maternal & fetal health over the world. In addition, rising investments in the development of fetal monitors are also expected to boost this market in coming five years. However, the high cost of equipment and prevalence of low birth rates in certain developed countries are expected to hamper the growth of this market. In spite of these restraints, emerging economies can be an opportunity for fetal monitoring analysis market.

On the basis of product, fetal monitoring analysis market is categorized into instruments & consumables and software. Instruments & consumables are further subdivided into ultrasound & ultrasonography, electronic fetal monitoring, fetal electrodes, fetal Doppler, uterine contraction monitor, telemetry solutions, accessories & consumables. In the product segment, instrument and consumables attributed for the largest share of the market and are expected to dominate this segment in coming five years. Ultrasound fetal doppler held more than 60% share of the market in 2016. A defect in birthrate and favorable government organizations initiatives to improve parental care are the major driving factors for the demand of instruments and consumables in coming five years.

Based on application, the fetal monitoring analysis market is divided into antepartum and intrapartum. The antepartum application has accounted for the largest share in application segment of fetal monitoring analysis market owing to increasing prevalence of congenital anomalies within the forecast period and expected to witness the fastest growth with a CAGR of more than 2.9% in coming five years. For example, congenital heart defects CHDs affect nearly about 40,000?births per year in the United States. The prevalence (the number of babies born with heart defect compared to the total number of births) of some CHDs, especially mild types, is increasing. The most common type of heart defect is a ventricular septal defect (VSD).

On the basis of the method, fetal monitoring analysis market is categorized into non-invasive and invasive methods. The non-invasive methods gained the largest share of this market in 2016. Growth in this segment is expected to fuel by increasing government and non-government initiatives to prevent maternal mortality worldwide. On the basis of portability, the fetal monitoring analysis market is divided into portable systems and non-portable systems. An end-user segment of fetal monitoring analysis market includes; hospitals, clinics, and others.

North America dominated this market by accounting for 41.5% in 2016 and is expected to grow at a high CAGR in coming five years. U.S. holds the largest market share in fetal monitoring analysis market in this region. Major driving factors include rising population, increasing prevalence of birth defects and preterm births. For instance, in the U.S. 3,000 pregnancies are affected by neural tube defects every year. Birth defects are the leading cause of infant deaths, accounting for 20% of all infant deaths.

Europe is expected to gain the second largest position in this market within the forecast period due to rising government initiatives for enhancing healthcare in coming five years. In Asia Pacific, a major share of this market is expected to contribute by China, India, and Japan due to favorable government initiative towards the development of healthcare infrastructure. Latin America and the Middle East and South Africa are expected to witness a healthy market growth within the forecast period.

Some of the key players of green building market such as Siemens Healthcare, Ge Healthcare, Analogic Corporation, Philips Healthcare, Covidien PLC, Neoventa Medical AB, Arjohuntleigh, Inc., Spacelabs Healthcare, Natus Medical Incorporated, Fujifilm Sonosite, Inc. among others.